InflaRx (IFRX) Invested Capital (2016 - 2026)

InflaRx has disclosed Invested Capital across 11 years of filings, most recently posting $43.2 million for Q1 2026.

• Invested Capital for Q1 2026 came in at $43.2 million, down 41.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $43.2 million (down 41.73% YoY), and the FY2025 annual result was $48.4 million, down 26.29% from the prior year.
• Invested Capital came in at $43.2 million for Q1 2026 at InflaRx, down from $48.4 million in the prior quarter.
• In the past five years, Invested Capital ranged from a high of $135.7 million in Q2 2023 to a low of $43.2 million in Q1 2026.
• The 5-year median for Invested Capital is $88.5 million (2024), against an average of $86.9 million.
• Across the five-year window, Invested Capital grew 27.92% in 2023 and sank 44.18% in 2024, its largest moves.
• InflaRx's Invested Capital stood at $90.1 million in 2022, then increased by 22.45% to $110.4 million in 2023, then sank by 40.54% to $65.6 million in 2024, then dropped by 26.29% to $48.4 million in 2025, then declined by 10.72% to $43.2 million in 2026.
• The last three Invested Capital figures came in at $43.2 million (Q1 2026), $48.4 million (Q4 2025), and $53.0 million (Q3 2025), per Business Quant data.